Episode Details

iX Biopharma is entering a transformative era, leveraging proprietary sublingual technology to disrupt the healthcare market. This episode examines their strategic expansion into the United States, focusing on high-stakes military partnerships and the rapid growth of personalised, direct-to-consumer medical solutions.

• The innovative pain management solution validated by the US Department of War for potential battlefield deployment

• How sublingual technology is revolutionising drug absorption for conditions ranging from acute pain to mental health

• The company's ambitious leap into the American compounding pharmacy market to deliver personalised wellness treatments